BR0010262A - Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol - Google Patents

Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol

Info

Publication number
BR0010262A
BR0010262A BR0010262-8A BR0010262A BR0010262A BR 0010262 A BR0010262 A BR 0010262A BR 0010262 A BR0010262 A BR 0010262A BR 0010262 A BR0010262 A BR 0010262A
Authority
BR
Brazil
Prior art keywords
composition
aerosol
active ingredient
aerosolizing
preparing
Prior art date
Application number
BR0010262-8A
Other languages
English (en)
Inventor
Rachel M Thurston
Praful K Shah
Michael E Placke
Original Assignee
Battelle Memorial Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute filed Critical Battelle Memorial Institute
Publication of BR0010262A publication Critical patent/BR0010262A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
    • B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
    • B05B5/0255—Discharge apparatus, e.g. electrostatic spray guns spraying and depositing by electrostatic forces only

Abstract

"COMPOSIçãO PARA FORMAR UM AEROSSOL PROCESSO DE PREPARAçãO E DE AEROSSOLIZAçãO DE UMA COMPOSIçãO, E, DISPOSITIVO GERADOR DE AEROSSOL". Uma composição usada em combinação com um dispositivo eletro-hidrodinâmico capaz de fornecer um ingrediente ativo ao sistema aerodigestivo do usuário. A composição compreende três ou opcionalmente quatro componentes básicos; um ingrediente ativo; um material veículo no qual o ingrediente ativo pode ser dissolvido, suspenso, ou emulsificado; um material ajustador de propriedades de aerossol que proporciona a composição com as características físicas requeridas para formar uma nuvem de aerossol por meio eletrostático ou eletro-hidrodinâmico; e opcionalmente pelo menos um excipiente que adicionalmente ajusta, conserva, estabiliza, ou intensifica o desempenho da composição.
BR0010262-8A 1999-05-03 2000-05-02 Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol BR0010262A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13221599P 1999-05-03 1999-05-03
PCT/US2000/011799 WO2000066206A2 (en) 1999-05-03 2000-05-02 Compositions for aerosolization and inhalation

Publications (1)

Publication Number Publication Date
BR0010262A true BR0010262A (pt) 2002-01-15

Family

ID=22453000

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010262-8A BR0010262A (pt) 1999-05-03 2000-05-02 Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol

Country Status (11)

Country Link
US (1) US6503481B1 (pt)
EP (1) EP1173245B1 (pt)
JP (1) JP2002543165A (pt)
AT (1) ATE274955T1 (pt)
AU (1) AU4979700A (pt)
BR (1) BR0010262A (pt)
CA (1) CA2370853C (pt)
DE (1) DE60013425T2 (pt)
ES (1) ES2226843T3 (pt)
MX (1) MXPA01011283A (pt)
WO (1) WO2000066206A2 (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345010B (en) * 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
AU2001226029A1 (en) * 2000-01-10 2001-07-24 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
BR0108077A (pt) * 2000-02-04 2002-10-22 Children S Hospital Res Founda Processo para reduzir placas ateroscleróticas em um mamìfero, método para tratamento da aterosclerose em um mamìfero, composição, métodos para prover proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo ou mistura deles, para células de um mamìfero tendo deficiência na proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo , para prover lipase de ácido lisossomal biologicamente ativa para células de um mamìfero tendo deficiência de lipase de ácido lisossomal biologicamente ativa, para prover lipase de ácido lisossoal biologicamente ativa para células de um mamìfero com aterosclerose, para tratamento da doença de wolman em um mamìfero, para tratamento de doença de armazenagem de colesteril éster em um mamìfero, e, para tratamento da aterosclerose em um mamìfero
CA2405169C (en) 2000-04-03 2011-07-26 Battelle Memorial Institute Devices and formulations
JP2004526674A (ja) * 2000-12-01 2004-09-02 バテル・メモリアル・インスティテュート 液体処方物中における生体分子の安定化のための方法
EP1370238B1 (en) 2001-03-22 2008-11-12 Battelle Memorial Institute Liquid formulations for electrohydrodynamic spraying containing polymer and suspended particles
US6737042B2 (en) 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
DE60230035D1 (de) 2001-05-24 2009-01-08 Alexza Pharmaceuticals Inc Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
WO2002094242A1 (en) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of rizatriptan or zolmitriptan through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
AU2002368202B2 (en) 2001-11-02 2008-06-05 Insert Therapeutics, Inc Methods and compositions for therapeutic use of RNA interference
WO2003041693A1 (en) 2001-11-09 2003-05-22 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
US7842310B2 (en) * 2001-11-19 2010-11-30 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
EP2098113A3 (en) 2002-10-25 2010-12-29 Battelle Memorial Institute Electrohydrodynamic spray for treating non-human animals
US7849850B2 (en) * 2003-02-28 2010-12-14 Battelle Memorial Institute Nozzle for handheld pulmonary aerosol delivery device
US20040187864A1 (en) * 2003-03-24 2004-09-30 Cindet, Llc Inhalation device and method
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
FR2855069B1 (fr) * 2003-05-22 2006-06-16 Solvay Procede pour la separation d'au moins un compose organique
ATE364402T1 (de) * 2004-03-10 2007-07-15 Shimoda Biotech Pty Ltd Stabile injizierbare diclofenac- zubereitungen
KR20050099311A (ko) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) 주사제용 항암제 조성물
MXPA06012240A (es) 2004-04-23 2007-01-31 Cydex Inc Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina.
AU2005247410A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
AU2005284706B2 (en) * 2004-09-14 2011-02-24 Battelle Memorial Institute Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor
CA2603730A1 (en) 2005-03-31 2006-10-05 Calando Pharmaceuticals, Inc. Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
CN102327285A (zh) * 2005-05-18 2012-01-25 普马特里克斯公司 改变粘膜内衬生物物理特性的配方
WO2007030375A2 (en) * 2005-09-08 2007-03-15 Children's Hospital Medical Center Lysosomal acid lipase therapy for nafld and related diseases
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
AU2006308716A1 (en) 2005-11-01 2007-05-10 Alnylam Pharmaceuticals, Inc. RNAi inhibition of influenza virus replication
WO2007083164A2 (en) * 2006-01-17 2007-07-26 Aerstream Technology Limited Liquid electrostatic spray composition
US7931020B2 (en) 2006-02-14 2011-04-26 Battelle Memorial Institute Dissociated discharge EHD sprayer with electric field shield
WO2007109097A2 (en) 2006-03-16 2007-09-27 Alnylam Pharmaceuticals, Inc. RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
JP2007254421A (ja) * 2006-03-24 2007-10-04 Canon Inc 吐出用液体、吐出方法、吐出用カートリッジ、吐出装置及び吐出用液体の液滴化方法
AU2007253803B2 (en) 2006-05-19 2012-05-24 Alnylam Pharmaceuticals, Inc. RNAi modulation of Aha and therapeutic uses thereof
US20090054333A1 (en) * 2006-10-17 2009-02-26 Antonio Giordano Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
US20100143264A1 (en) * 2007-02-01 2010-06-10 Battelle Memorial Institute Compositions for aerosolization of highly conductive solutions
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
ES2565219T3 (es) * 2008-03-17 2016-04-01 Discovery Laboratories, Inc. Adaptador de circuito de ventilación y sistema proximal de administración de aerosol
CN102037123A (zh) 2008-04-04 2011-04-27 卡兰多制药股份有限公司 Epas1抑制剂的组合物和用途
CA2683353C (en) 2008-10-22 2015-12-15 Trudell Medical International Modular aerosol delivery system
KR20120093066A (ko) 2009-05-29 2012-08-22 스미또모 가가꾸 가부시키가이샤 신경영양인자의 활성이 관여하는 질환의 치료 또는 예방제
US20110174304A1 (en) * 2010-01-21 2011-07-21 Triplett Ii Michael D Electrohydrodynamic aerosolization device having a time varying voltage
US20120048963A1 (en) 2010-08-26 2012-03-01 Alexza Pharmaceuticals, Inc. Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
EP2611438B1 (en) 2010-08-30 2020-04-01 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
KR101915241B1 (ko) 2010-09-29 2018-11-06 풀매트릭스 오퍼레이팅 컴퍼니, 인크 흡입용의 1가 금속 양이온 건조 분말
EP2621488B1 (en) 2010-09-29 2018-11-07 Pulmatrix Operating Company, Inc. Cationic dry powders
WO2012090683A1 (en) * 2010-12-28 2012-07-05 Sumitomo Chemical Company, Limited Method of treating target space, and liquid particles
AU2011265562A1 (en) 2011-01-12 2012-07-26 Sumitomo Chemical Company, Limited Method of controlling harmful arthropod, composition, and electrostatic spray device
US20120302954A1 (en) * 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
JP2013070767A (ja) * 2011-09-27 2013-04-22 Panasonic Corp 機能性微粒子放出装置
US9089529B2 (en) 2011-10-25 2015-07-28 Prothena Therapeutics Limited Antibody formulations and methods
NZ629722A (en) 2012-02-29 2017-03-31 Pulmatrix Operating Co Inc Inhalable dry powders
RU2015146871A (ru) 2013-04-01 2017-05-10 Пулматрикс, Инк. Сухие порошки с тиотропием
US9802010B2 (en) * 2013-11-22 2017-10-31 Noveome Biotherapeutics, Inc. Interproximal drug delivery device
JP2017505348A (ja) 2014-02-10 2017-02-16 パタラ ファーマ リミテッド ライアビリティ カンパニー 肺疾患治療のための肥満細胞安定剤
EP3653207A1 (en) 2014-02-10 2020-05-20 Respivant Sciences GmbH Mast cell stabilizers treatment for systemic disorders
SG11201700484SA (en) * 2014-08-08 2017-02-27 Shenzhen Hightide Biopharmaceutical Ltd Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
CN114522152A (zh) 2015-03-11 2022-05-24 艾利斯达医药品公司 气道中的防静电材料用于热气溶胶凝结方法的用途
GB201509820D0 (en) * 2015-05-06 2015-07-22 Nicoventures Holdings Ltd Aerosol delivery device
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
WO2018044942A1 (en) 2016-08-31 2018-03-08 Patara Pharma, LLC Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis
CA3210753A1 (en) 2021-02-09 2022-08-18 University Of Georgia Research Foundation, Inc. Human monoclonal antibodies against pneumococcal antigens
WO2023198757A1 (en) 2022-04-14 2023-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659012A (en) 1983-08-18 1987-04-21 Imperial Chemical Industries Plc Electrostatic spraying process and apparatus
GB8604328D0 (en) * 1986-02-21 1986-03-26 Ici Plc Producing spray of droplets of liquid
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
US6105571A (en) 1992-12-22 2000-08-22 Electrosols, Ltd. Dispensing device
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB2327895B (en) 1997-08-08 2001-08-08 Electrosols Ltd A dispensing device
US6158431A (en) 1998-02-13 2000-12-12 Tsi Incorporated Portable systems and methods for delivery of therapeutic material to the pulmonary system
GB2334461B (en) 1998-02-20 2002-01-23 Bespak Plc Inhalation apparatus
FR2776538B1 (fr) 1998-03-27 2000-07-21 Centre Nat Rech Scient Moyens de pulverisation electrohydrodynamique
GB2345010B (en) 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method

Also Published As

Publication number Publication date
ES2226843T3 (es) 2005-04-01
US6503481B1 (en) 2003-01-07
AU4979700A (en) 2000-11-17
CA2370853A1 (en) 2000-11-09
WO2000066206A2 (en) 2000-11-09
DE60013425D1 (de) 2004-10-07
ATE274955T1 (de) 2004-09-15
WO2000066206A3 (en) 2001-02-08
DE60013425T2 (de) 2005-09-08
MXPA01011283A (es) 2002-11-04
CA2370853C (en) 2007-07-10
JP2002543165A (ja) 2002-12-17
EP1173245A2 (en) 2002-01-23
EP1173245B1 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
BR0010262A (pt) Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol
AR064614A1 (es) Producto combinado par controlar parasitos en animales
ATE279469T1 (de) Thermisch härtbare, wässrige zusammensetzungen
DE60123245D1 (de) Artikel zur abgabe von flüchtigen produkten
BRPI0511802A (pt) processo para criação de meios para uso em separadores de ar/óleo
DK0888110T3 (da) Mikropartikler af en kompositgel som bærere for aktive midler
ATE504815T1 (de) Verfahren und vorrichtung zur steuerung von dispersionskräften
AR025055A1 (es) Composiciones farmaceuticas
SE0100901D0 (sv) New composition
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
AR036640A1 (es) Formulaciones y uso de las mismas
BR0212253A (pt) Material e artigo para fumar
BR0110751A (pt) Dispositivo
ATE415817T1 (de) Agrochemische formulierungen
BRPI0513264A (pt) dispositivo de pulverização
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
DE59902006D1 (de) Wirkstoffhaltige aromatische copolyester
ES2182805T3 (es) Agentes de adhesion modificados con nanoparticulas para agentes de revestimiento y la utilizacion de los mismos.
BR9909806A (pt) Processo de moagem com energia fluida e aparelho
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
UY27753A1 (es) Formulación farmacéutica que comprende melatonina.
BR0215627A (pt) Suporte de componente e gerador de radioisótopos
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.